FDA approves Zepbound, a weight loss drug, to treat obstructive sleep apnea
Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep apnea.
16 across the spectrum · tap a section to jump
The story so far
2 developments- Dec 20, 2024FDA approves weight loss drug Zepbound for sleep apnea
- Dec 23, 2024Only center coverage:Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound
Who covered each development
No new developments
Quiet for 645 daysLast development · Dec 23, 2024 — Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound
Left
5 viewpointsThe FDA just approved Eli Lilly's Zepbound for sleep apnea — and Medicare coverage could be next
FDA approves weight-loss drug Zepbound for obstructive sleep apnea
Center
9 viewpointsLilly Rises on FDA Approval of Weight-Loss Drug-Zepbound for Sleep Apnea
Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound
Right
2 viewpointsOther outlets
International, entertainment and tech outlets, by their rating. Not counted in the bar above. How we count coverage
Left
1 articleCenter
0 articlesNone
Right
0 articlesNone